.Merck beats revenues desires, rears sales overview on strong requirement for best medications like Keytruda CNBCMerck & Co. (MRK United States) Beats Income Estimates as Keytruda Sales Rise BloombergMerck Stock: Pharma Giant Posts Solid Outcomes, But Outlook Drops Short Real estate investor's Business DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck trumps income and also purchases assumptions among Keytruda strength, yet provides mixed full-year overview MarketWatch.